Estrenes
AssigneeWyeth
InventorsMichael Z. Kagan, Fangming Kong, Leonard A. McDonald, Panolil Raveendranath, Syed M. Shah, Joseph Zeldis
Life of this patent
Estimating the term…
Abstract
This invention provides a pharmaceutically acceptable salt of 3β-hydroxy-5(10)-estrene-17-one 3-sulfate ester and a pharmaceutically acceptable salt of 3α-hydroxy-5(10)-estrene-17-one 3-sulfate ester, which are useful as an estrogens.
Claims2
A compound which is a pharmaceutically acceptable salt of 3β-hydroxy-5(10)-estrene-17-one 3-sulfate ester wherein the pharmaceutically acceptable salt of the 3-sulfate ester is an alkali metal salt, alkaline earth metal salt, ammonium salt, alkylammonium salt containing 1-6 carbon atoms, or dialkylammonium salt containing 1-6 carbon atoms in each alkyl group, or trialkylammonium salt containing 1-6 carbon atoms in each alkyl group.
A compound which is a pharmaceutically acceptable salt of 3α-hydroxy-5(10)-estrene-17-one 3-sulfate ester wherein the pharmaceutically acceptable salt of the 3-sulfate ester is an alkali metal salt, alkaline earth metal salt, ammonium salt, alkylammonium salt containing 1-6 carbon atoms, or dialkylammonium salt containing 1-6 carbon atoms in each alkyl group, or trialkylammonium salt containing 1-6 carbon atoms in each alkyl group.
Dependencies are inferred from the claim text.